Skip to main content

King Wealth

SEC CIK
0001568235
Latest filing
Aug 5, 2026

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by King Wealth, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings

Shares (Q2 2026)
32,799
Value
$14.0K
% of portfolio
<0.1%
Quarters held
10
Since Q1 2024
Holdings of HRTX by King Wealth, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202632,799$14.0K<0.1%00.0%UnchangedHolders
Q1 202632,799$26.0K<0.1%+2,000+6.5%AddedHolders
Q4 202530,799$40.0K<0.1%+1,000+3.4%AddedHolders
Q3 202529,799$38.0K<0.1%+1,000+3.5%AddedHolders
Q2 202528,799$60.0K<0.1%+2,000+7.5%AddedHolders
Q1 202526,799$59.0K<0.1%00.0%UnchangedHolders
Q4 202426,799$41.0K<0.1%+3,500+15.0%AddedHolders
Q3 202423,299$46.0K<0.1%+8,000+52.3%AddedHolders
Q2 202415,299$54.0K<0.1%+5,200+51.5%AddedHolders
Q1 202410,099$28.0K<0.1%+10,099NewHolders